Table 5.
Data of oxygen saturation, neuromuscular strength and range of motion in baseline, pretreatment and posttreatment moments.
Pretreatment post-treatment intragroup comparison
ES standardized (90% CL) intragroups
Chances
QA
ES standardized (90% CL) between groups
Chances
QA
SmO
2
Rest
NVFR
0.28 (-0.09;0.65)
64/43/2
Possibly
-0.10 (0.49;-0.70)
20/41/39
Unclear
VFR
0.41 (-0.08;0.91)
77/21/2
Likely
After ten squats
NVFR
1.23 (0.44;2.01)
98/1/0
Very likely
0.21 (0.74;-0.33)
10/39/51
Unclear
VFR
0.96 (0.36;1.55)
98/2/0
Very likely
CMJ
NVFR
0.42 (0.3;0.54)
100/0/0
Very likely
-0.09 (-0.24;0.05)
0/89/11
Unclear
VFR
0.29 (0.2;0.38)
95/5/0
Very likely
Hip joint ROM
Active
NVFR
0.53 (0.32;0.73)
99/1/0
Very likely
0.31 (-0.02;0.64)
71/28/1
Unclear
VFR
0.91 (0.63;1.19)
100/0/0
Very likely
Passive
NVFR
0.34 (0.14;0.53)
88/12/0
Likely
0.36 (0.01;0.72)
78/22/1
Likely
VFR
0.71 (0.45;0.97)
100/0/0
Very likely
Knee joint ROM
Active
NVFR
0.62 (0.48;0.76)
100/0/0
Very likely
0.19 (-0.01;0.39)
47/52/0
Unclear
VFR
0.48 (0.33;0.62)
100/0/0
Very likely
Passive
NVFR
0.43 (0.23;0.63)
97/3/0
Very likely
0.05 (-0.18;0.28)
14/82/4
Unlikely
VFR
0.26 (0.1;0.42)
74/26/0
Possibly
ES, effect size; CL, confidence limits; QA, qualitative assessment; CMJ, countermovement jump; SmO
2
, muscle oxygen saturation; ROM, range of motion.